Article
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.
PloS one - 1 Jan 2015
Zorzan Eleonora, Hanssens Katia, Giantin Mery, Dacasto Mauro, Dubreuil Patrice
Abstract excerpt
INTRODUCTION: Both canine cutaneous mast cell tumor (MCT) and human systemic mastocytosis (SM) are characterized by abnormal proliferation and accumulation of mast cells in tissues and, frequently, by the presence of activating mutations in the receptor tyrosine kinase V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog (c-KIT), albeit at different incidence (>80% in SM and 10-30% in MCT). In the last...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.